Menu UF Health Home Menu
 
Dr. Shannon Boye
lab tour cropped
Prev Next

Retinal Gene Therapy Group

Established in 1994, AAV vectors from the RGTG were the first to:
(Click on the image to see a larger view)

Retinal Gene Therapy Timeline

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Recent News

Department of Ophthalmology faculty receive 2014 Technology Innovator Awards

Jul 13th, 2015

Drs. Shannon Boye, William Hauswirth and Sanford Boye were honored this year at the Univerisy of Florida’s Celebration of Innovation for successfully transferring their world-class research to a commercial partner. […]

William Hauswirth receives 2014 OIS Innovator Award

Nov 11th, 2014

William Hauswirth, Ph.D. was co-awarded the 2014 OIS Innovator Award in Chicago at the Ophthalmology Innovation Summit, a full day pre-meeting of the American Academy of Ophthalmology annual meeting. He […]

Drs. Shannon Boye and Alfred Lewin each receive Individual Investigator Awards from the Foundation Fighting Blindness

Sep 12th, 2014

Dr. Boye’s grant will help support development of an AAV- based gene therapy to treat the retinal phenotype of the severe deaf/blinding disease, Usher syndrome type 1B, which is caused […]

Dr. Shannon Boye’s work on AAV vector development featured in Ophthalmology Times

Jul 24th, 2014

Dr. Shannon Boye is featured in an article from Ophthalmology Times about advances in the AAV vector for retinal gene therapy. Read the article here.